Incongruence between Cardiorespiratory Fitness and Subjective Reports of Physical Activity in Multiple Sclerosis: A Focus on Sex Differences

Buragadda, Syamala; Snow, Nicholas J.; Gou, Alan P. C.; McShane, Joshua N.; Newell, Caitlin J.; Ploughman, Michelle

doi:https://doi.org/10.1155/2024/6055245

Multiple Sclerosis International

On this page

Abstract Introduction Materials Results Discussion Conclusions Data Availability Disclosure Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2024 | Article ID 6055245 | https://doi.org/10.1155/2024/6055245

Incongruence between Cardiorespiratory Fitness and Subjective Reports of Physical Activity in Multiple Sclerosis: A Focus on Sex Differences

Syamala Buragadda,¹Nicholas J. Snow,¹Alan P. C. Gou,¹Joshua N. McShane,¹Caitlin J. Newell,¹and Michelle Ploughman¹

Academic Editor: Sarah Orton

Received28 Sept 2023

Revised03 Mar 2024

Accepted27 Mar 2024

Published24 Apr 2024

Abstract

Purpose. The link between moderate- to vigorous-intensity physical activity (MVPA) and cardiorespiratory fitness in individuals with multiple sclerosis (MS) remains unclear. This study examined the relationship between self-reported MVPA and objectively assessed cardiorespiratory fitness, emphasizing sex differences. Methods. 107 adults with MS (77 females), aged () years, were recruited from a local MS clinic. Fitness was measured as maximal oxygen uptake (V̇O_2max) during a graded maximal exercise test using a recumbent stepper. MVPA (24-hour recall) was estimated as the duration of MET (metabolic equivalent of task). MET-minutes were calculated by multiplying MET by duration. We explored sex differences in self-reported MVPA, cardiorespiratory fitness, and disability; examined sex differences in associations between these variables; and investigated whether MET-minutes of MVPA predicted V̇O_2max in females and males. Results. Mean V̇O_2max was 24.79 mL·kg^-1·min^-1, indicating poor cardiorespiratory fitness levels, despite high levels of self-reported MVPA ( MET-minutes). Fifty-three percent of males and 40% of females had V̇O_2max levels below the 20^th age- and sex-standardized population percentile, indicating poor cardiorespiratory fitness. There were statistically significant associations between MVPA and V̇O_2max (, ), as well as disability and V̇O_2max (, ), in females but not males. A regression model using sex, age, body mass, disability, and MVPA to estimate V̇O_2max was valid in predicting V̇O_2max values that were statistically equivalent to those measured in the laboratory in females but not males. However, the inclusion of MVPA did not add to the predictive value of this equation. Conclusions. Despite reporting high levels of MVPA, people with MS had poor cardiorespiratory fitness. MVPA, fitness, and disability were associated in females only, indicating that sex differences should be considered in fitness appraisal. Self-reported MVPA did not predict fitness, suggesting 24-hour recall may not be representative of true activity or fitness levels in persons with MS. Future work should examine sex differences in associations between MVPA and fitness using objective measures such as accelerometry.

1. Introduction

Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system, characterized by chronic disability accumulation and episodes of new neurologic impairment with incomplete recovery [1]. Among people with MS, vascular comorbidities are associated with accelerated neurodegeneration, earlier disability, and loss of independence [2, 3]. Lifestyle factors are crucial for vascular risk management and the mitigation of disability accumulation [1, 4]. Exercise and physical activity are critical interventions for the promotion of vascular, metabolic, and brain health and should be a routine part of MS care [5–9]. Guidelines recommend that people with MS engage in at least 150 minutes of moderate-to-vigorous physical activity (MVPA) per week [10, 11]. Unfortunately, individuals with MS are less active and more sedentary than healthy controls and even persons with other neurologic disorders like stroke and spinal cord injury [12]. Individuals with MS report disease-related impairments, fatigue, and logistical challenges as barriers to engaging in physical activity [13]. Health professionals cite concerns about patient fatigue and safety as barriers to prescribing physical activity, despite evidence of its safety in MS [14, 15].

One of the first steps in prescribing MVPA is determining the individual’s level of fitness. The gold standard cardiorespiratory fitness assessment involves graded maximal exercise testing with indirect calorimetry to measure maximal oxygen uptake (V̇O_2max) [16]. V̇O_2max testing in MS is a valid and reliable measure of aerobic capacity [17] and shows good relationships with disease-specific and general health-related outcomes of the International Classification of Functioning, Disability, and Health model [18]. However, maximal exercise testing and indirect calorimetry require specialized equipment, trained evaluators, and a highly controlled environment. These requirements often preclude maximal exercise testing in real-world clinical or community settings outside the laboratory setting [19]. In some contexts, these limitations can be overcome using submaximal exercise testing or field tests [20]. However, submaximal exercise testing tends to have the greatest validity in low or minimally disabled persons with MS [21, 22], and field test performance may better reflect functional capacity rather than cardiorespiratory fitness or exercise tolerance [22, 23]. When a formal fitness test is impractical, health professionals sometimes rely on patients’ subjective reports of physical activity recall. Self-report questionnaires are considered reliable, easy to administer, and more affordable and accessible than fitness testing [24]. In healthy controls, there is good concordance between self-reported physical activity levels, self-appraised fitness, and V̇O_2max [25]. However, in MS and other clinical populations, greater susceptibility to recall bias, perceived social desirability, and expectations of others can contribute to the misrepresentation of physical activity levels [26, 27].

MS is a disease with known sex differences, including incidence and onset, disease progression, and the nature and severity of physical and psychosocial impairments [1, 28, 29]. In general, when it comes to reporting cardiorespiratory fitness and physical activity levels among individuals with MS, sex differences are typically overlooked [18, 30]. One study of 92 persons with MS (58 females) found no significant associations between self-reported physical activity and cardiorespiratory fitness (peak V̇O₂) [31]. However, the authors did not discriminate between different intensities of physical activity nor examine sex differences in physical activity or its association with peak V̇O₂ [31]. The study sample was recruited from a waiting list of individuals referred for admission to inpatient rehabilitation, so it was likely not representative of people with MS with stable disease who are capable of exercising independently [31]. In another larger study of 380 individuals with MS (249 females), females were less likely to reach V̇O_2max before volitional exhaustion compared to males [32]. Also, this study did not compare cardiorespiratory fitness and physical activity levels between the sexes. It is important to note that the study participants were hospital inpatients and may not be representative of independent, community-dwelling individuals. Taken together, these findings allude to the lack of evidence on sex differences in self-reported physical activity levels and cardiorespiratory fitness in MS, highlighting the need for further research to fill existing knowledge gaps.

To address these gaps, the present study is aimed at (1) exploring sex differences in self-reported MVPA and V̇O_2max; (2) examining relationships between self-reported MVPA, V̇O_2max, and disability status, with an emphasis on sex differences; and (3) determining whether self-reported MVPA could predict V̇O_2max in females and males with MS.

2. Materials and Method

2.1. Participants

We conducted this cross-sectional study in a neurorehabilitation research laboratory located within a tertiary rehabilitation hospital. Following institutional Health Research Ethics Board approval (HREB#: 2015.103), participants provided informed written consent as per the Declaration of Helsinki. The study sample was recruited from a local MS neurology clinic, and participants were independently able to walk with stable disease.

We recruited consecutive adults diagnosed with MS—using the 2010 or 2017 iterations of the McDonald criteria [33, 34]. We included participants who were aged 18-65 years, had no relapses or new disease activity for ≥3 months, could walk independently with or without gait aides (Expanded Disability Status Scale (EDSS) 0-6) [35], and had no contraindications to exercise [36]. We excluded individuals who screened positive for mild cognitive impairment, on the Montréal Cognitive Assessment [37]. We extracted EDSS scores and sex assigned at birth from health records.

We planned sample size estimation based on our intention to derive a prediction equation for V̇O_2max using participant characteristics and self-reported MVPA. We estimated the target sample size using GPower v3.1.9.7 (Aichach, Germany) [38], using data from a recent meta-analysis that suggested sex differences account for up to 36% of the variance in V̇O_2max [18]. Based on the coefficient of variation () and effect size () gleaned from the study [18], using and power ) for a multiple linear regression with up to five predictors, we estimated that 54 total participants (27 females, 27 males) would be required to derive a prediction equation for V̇O_2max. To validate the prediction equation, we estimated that an additional 54 participants (27 females, 27 males) would be required, resulting in a total target sample size of 108. This approach was taken to ensure the validity of the predictive model [39].

2.2. Self-Reported MVPA

We asked the participants to recall all activities during the previous 24 hours, describing the details of the activity, duration, and intensity [40]. The 24-hour previous-day recall is a valid tool to estimate active and sedentary behaviors in adults of varying fitness levels (Kozey [40–44]). Previous-day recall methods agree with objective measurements of physical activity, direct observations, and energy expenditure (Kozey [40–42, 44]); and they minimize reporting errors compared to longer-term questionnaires by reducing recall bias due to forgetting (Kozey [40, 41]). Reported activities included sleeping, sitting, walking, activities of daily living, home exercises, and sports, such as running and bicycling. Because of evidence that persons with MS have problems with accurate recall of duration [45], we cleaned self-reported activity data by omitting all values under 10 minutes per day and truncating values over 240 minutes per day [46]. We converted self-reported activities to metabolic equivalents of task (MET) using the 2011 Compendium of Physical Activities [47]. Based on the World Health Organization threshold values, we classified activities with MET METs as MVPA [48]. We calculated MET-minutes of MVPA by multiplying the MET value of each activity by the duration in minutes [48] and reported values for the previous 24 hours.

2.3. Cardiorespiratory Fitness

We measured cardiorespiratory fitness using a graded maximal exercise test on a total body recumbent stepper (NuStep T4r, Ann Arbor, MI, USA) [49, 50]. We instructed the participants to avoid alcohol and recreational drugs for ≥24 hours, to avoid caffeine and nicotine for ≥6 hours, and to sleep for ≥6 hours. We measured height (cm), body mass (kg), and body mass index (BMI; kg·m^-2) with a calibrated device (Health-O-Meter®, McCook, IL, USA), familiarized the participants with the experimental setup, and adjusted the arm and leg attachments of the ergometer based on participant limb length. Participants wore a mask connected to a two-way non-rebreathing valve (Hans Rudolph, Inc., Shawnee, KS, USA). An automated open-circuit indirect calorimetry system with calibrated gas analyzers (Model S-3A and Anarad AR-400; Ametek, Pittsburgh, PA) and tachometer (Model S-430; Vacumetrics/Vacumed Ltd., Ventura, CA) measured expired gas and breathing volumes for breath-by-breath analysis (AEI Technologies, Inc., Pittsburgh, PA, USA). A chest-worn heart rate (HR) monitor transmitted the HR data wirelessly (H10, Polar Electro, Oy, Finland).

Resting blood pressure, V̇O₂, and HR were measured 5 minutes before exercise. During the test, participants maintained a stepping rate of 80 per minute. The exercise test began at a load level of 3 (20 watts) on a standard scale of 1-10 and increased by 20 watts every 2 minutes. If the participants did not stop by load level 10, we increased the stepping rate by 10 per minute every 2 minutes. Criteria for test termination were (1) volitional exhaustion, (2) inability to maintain workload, or (3) signs of excessive fatigue [49]. We recorded relative V̇O₂ (normalized to body mass; mL·kg^-1·min^-1), HR (bpm), and rating of perceived exertion (RPE; 10 points) [51] at rest before exercise, every 2 minutes during exercise, and after exercise. Participants achieved true V̇O_2max if they met two or more of the following criteria: (1) no increase in absolute mL·min^-1, despite increasing workload; (2) respiratory exchange ; (3) of the age-predicted maximum; and/or (4) [52]. Besides reporting relative V̇O_2max, we also reported age- and sex-adjusted percentile ranks of cardiorespiratory fitness per the American College of Sports Medicine (ACSM) [16]. Individuals with a V̇O_2max below the 20^th percentile for their age and sex have an elevated risk of all-cause mortality [53].

2.4. Statistical Analysis

We performed all statistical analyses using SPSS version 27 (IBM Corporation, Armonk, NY, USA). We tested data distributions for normality using the Shapiro-Wilk test and visual inspection of histograms and Q-Q plots. We conducted parametric and nonparametric tests for normal and nonnormal data, respectively. All tests were two-tailed, with the statistical significance threshold at .

Descriptive statistics were reported as proportions (%), mean (standard deviation (SD)), or median (range) for categorical, normal continuous, or nonnormal continuous data, respectively. Sex differences were assessed using parametric (unpaired -test) or nonparametric tests (Mann–Whitney -test or Pearson chi-square test). We estimated effect sizes for -tests using Cohen’s with 95% confidence intervals (CI) and interpreted them as trivial (<0.2), small (0.2-0.5), medium (0.5-0.8), and large (≥0.8) [54]. For -tests, we used effect sizes categorized as trivial (<0.1), small (0.1-0.3), medium (0.3-0.5), or large (>0.5) [54]. Chi-square effect sizes were calculated using Cohen’s with 95% CI and interpreted as above for Cohen’s [54].

We conducted the Spearman Rho () correlations to explore associations between self-reported MVPA, cardiorespiratory fitness, and EDSS, with correlation coefficients interpreted as trivial (<0.1), weak (0.1-0.3), moderate (0.3-0.5), and strong (≥0.5) [54]. Correlations were performed both for the total sample and separately by sex. Sex differences were compared using Fisher -transformations and Cohen’s -effect sizes with 95% CI, interpreted as above for Cohen’s and [54].

To determine whether self-reported MVPA predicted V̇O_2max, we performed a multiple linear regression using sex, age, body mass, EDSS, and MET-minutes of MVPA as predictors. These variables were chosen based on their documented contribution to V̇O_2max [17, 31] and sex differences in cardiorespiratory fitness [55, 56]. We compared combinations of predictor variables using stepwise linear regression and chose the final model as the combination with the lowest Akaike information criterion (AIC) value. The final model was entered as a standard multiple regression and included each of the above variables—sex, age, body mass, EDSS, and MET-minutes of MVPA. Using a random number generator, we assigned participants to either a regression derivation group ( (34 females, 16 males)) or validation group ( (43 females, 14 males)). The regression equation was derived from the derivation group and validated in the validation group. Groups did not differ significantly in demographics, self-reported physical activity, or V̇O_2max (), except for higher EDSS in the validation group (median (range): test group 1.5 (0-6), validation group 2.0 (0-6), ). See Predicting V̇O_2max from Self-Reported MVPA, under Results, for more information.

We verified the assumption of independence of observations using a Durbin-Watson (DW) statistic of ~2 (); linearity and homoscedasticity between independent and dependent variables by inspecting plots of unstandardized predicted values versus studentized residuals (); and lack of multicollinearity by ensuring Pearson correlations between independent variables were ≥0.7 (Pearson ) and variance inflation factors (VIF) were <10 () [57]. There were no outliers (±3 SD from the mean). We confirmed normal distribution of residuals by inspecting histogram and P-P plots for an approximate bell curve and diagonal line, respectively [57]. The model’s overall coefficients of variance ( and adjusted ) and unstandardized coefficients (, with standard errors) were reported for the derivation group to generate the V̇O_2max prediction equation for later validation.

We validated the model using the cross-validation approach [39] and computed predicted V̇O_2max values in the validation group using the regression equation from the derivation group [58]. The validity of these estimates was assessed using equivalence testing and Bland-Altman plots [59]. We employed the two one-sided test (TOST) approach to equivalence testing, with paired sample -tests [60]. We set the equivalence threshold (standardized effect size of interest (Cohen’s )) at 10% above or below the measured V̇O_2max in the derivation group because this is an acceptable margin of error between predicted versus measured V̇O_2max in other work that devised V̇O_2max prediction equations (Cohen’s value of |0.42|) [58]. Nonequivalence was determined if the effect sizes (Cohen’s ) of measured versus predicted V̇O_2max values in the validation group exceeded ±0.42 [60]. Both whole group validation and sex differences in the performance of the regression equation were explored using the TOST approach. We constructed the Bland-Altman plots [59] to assess the degree of error between predicted versus measured V̇O_2max and determine the error pattern in females and males [58]. Using this approach, predicted V̇O_2max values were considered valid if (1) the difference between, and average of, predicted and measured V̇O_2max values was correlated and (2) predicted V̇O_2max values fell within 2 SD of measured V̇O_2max values [59].

3. Results

3.1. Participants

Out of 120 participants screened, 13 were excluded due to exercise contraindications [36], leaving 107 individuals in the final sample. The age was years, with a majority being females ( (71.9%)) and 88.8% having relapsing-remitting MS (). The median (range) EDSS was 2.0 (0-6.0). In terms of sex differences, males were significantly taller and heavier () than females; but other demographic and disease characteristics were not significantly different between sexes (Table 1).

3.2. Self-Reported MVPA and Cardiorespiratory Fitness

On average, participants reported engaging in approximately 90 minutes of MVPA (>3.0 METs) in the last 24 hours, accumulating 412.5 MET-minutes. These 24-hour values were close to the recommended weekly 450 MET-minutes of MVPA [61, 62]. Only 10 participants (9.3%) reported no physical activity. The average V̇O_2max for participants was 24.80 ± (7.70), placing the median participant in the 10^th fitness percentile (poor) [16] (Table 2). Based on the criteria outlined above, 84 participants (78.5%) reached their true V̇O_2max. For the remaining 23 participants (21.5%), peak V̇O₂ values are reported as V̇O_2max.

There was no significant difference between males and females regarding self-reported MVPA () (Table 2 and Figure 1). The proportions of females ( (79.2%)) and males ( (76.7%)) who reached true V̇O_2max were not significantly different (, ). Males demonstrated a 27% higher relative V̇O_2max, with a large effect size, compared to females (). When cardiorespiratory fitness was expressed in terms of age- and sex-normalized values, males ranked significantly higher, with a median (range) percentile score of 10 (4-95) versus 5 (4-90) for females and a small effect size () (Table 2 and Figure 1). Approximately half of both females’ and males’ cardiorespiratory fitness ranks fell below the 20^th percentile.

(a)

(b)

(c)

(d)

Figure 1

Violin plots illustrating female (light grey) and male (dark grey) moderate- to vigorous-intensity physical activity (MVPA) and cardiorespiratory fitness (maximum oxygen uptake (V̇O_2max)). Squares are individual data points. Shaded regions represent the distribution of the data. Dashed and dotted lines represent the median and interquartile range (IQR), respectively. (a) Metabolic equivalent of task (MET-minutes of MVPA, (b) minutes of MVPA, (c) age- and sex-normalized V̇O_2max percentiles (%ile), and (d) V̇O_2max (mL·kg^-1·min^-1).

3.3. Associations between MVPA, V̇O_2max, and Disability

In the total sample, we observed statistically significant positive associations between higher V̇O_2max and higher MET-minutes of MVPA (, ), as well as higher V̇O_2max and lower disability (EDSS) (, ). There was no statistically significant relationship between self-reported MVPA and disability (, ) (Table 3).

When we analyzed sexes separately, we found a statistically significant yet weak relationship between higher V̇O_2max and greater MVPA among females (, ) but not males (). As well, lower disability (EDSS) was significantly associated with higher V̇O_2max in females (, ) but not males (, ) (Table 3).

To ascertain whether the lack of statistically significant correlations in males was due to sample size insufficiency, we calculated post hoc sample size requirements based on current sample size ( males), statistical power, correlation coefficients, and values using GPower v3.1.9.7 (Aichach, Germany) [38]. To achieve a statistically significant association between MET-minutes of MVPA and relative V̇O_2max (, , ), a target sample size of 185 males would be required. For a statistically significant association between EDSS and relative V̇O_2max (, , ), 102 males would be required. To achieve a statistically significant association between EDSS and percentile ranked V̇O_2max (, , ), 445 males would be required. Given V̇O_2max was significantly associated with both MET-minutes of MVPA EDSS in our sample of 77 females, we interpret this to represent a sex difference, rather than a function of a low sample size of males.

3.4. Predicting V̇O_2max from Self-Reported MVPA

Thirty-four females and 16 males () were used to derive the regression equation and 43 females and 14 males () to validate the equation. Except for a small yet statistically significant difference in EDSS, these groups were not significantly different in terms of demographic or disease characteristics, self-reported MVPA, or objectively measured cardiorespiratory fitness (Table 4).

In the regression derivation group, the overall model was statistically significant (, ). The combination of sex, age, body mass, EDSS, and MVPA accounted for 35%-42% of variance in V̇O_2max (, adjusted ) (Table 5). MVPA was the only variable that did not significantly contribute to the predictive ability of the model (). The model met all assumptions. Using the multiple regression, we derived the following equation to analyze sex differences in the prediction of V̇O_2max: .

When we ran the regression in the validation group, the overall model remained statistically significant (, , , adjusted ). Again, MET-minutes of MVPA in the last 24 hours did not reach statistical significance as a predictor variable (). In the validation group, measured and predicted V̇O_2max values were both equivalent ( (± -0.16 to +0.36)) and not significantly different (; Table 6).

When considering sex differences, we found that measured and predicted V̇O_2max values were both equivalent ( (± -0.30 to +0.30)) and not significantly different (), in females (Table 6). However, in males, although not significantly different (), the measured and predicted V̇O_2max values were also nonequivalent ( (± -0.15 to +0.95); Table 6). Figure 2 illustrates the Bland-Altman plots of measured and predicted V̇O_2max values in females (Figure 2(a)) and males (Figure 2(b)) in the validation group. For both females and males, the difference between, and average of, predicted and measured V̇O_2max values was significantly correlated (females: , ; males: , ). The plots show that predicted V̇O_2max values for all participants fell within 2 SD of measured V̇O_2max within both sexes.

(a)

(b)

Figure 2

Bland-Altman plots of measured and predicted cardiorespiratory fitness (V̇O_2max; mL · kg^-1·min^-1) in the validation group of participants (; 43 females, 14 males). Based on the regression equation V̇O_2max (mL · min^-1 · kg^-1) = (8.211 × sex (1 = F, 2 = M)) − (0.228 × age) − (0.247 × body mass) − (0.996 × EDSS) + (0.004 × MET − minutes of MVPA) + 44.737, obtained from the derivation group of participants (; 34 females, 16 males). The -axis represents the average of measured and predicted V̇O_2max values, and the -axis represents the difference between measured and predicted values. Dashed lines represent the mean and ±2 standard deviations (SD) from the mean. (a) and (b) demonstrate the prediction equation in females and males, respectively.

4. Discussion

This study is aimed at (1) exploring sex differences in self-reported MVPA and V̇O_2max; (2) examining relationships between self-reported MVPA, V̇O_2max, and disability status, with an emphasis on sex differences; and (3) determining whether self-reported MVPA could predict V̇O_2max in females and males with MS.

MS participants had low levels of cardiorespiratory fitness despite high self-reported levels of MVPA in the last 24 hours, suggesting incongruence between objective fitness levels and self-reported estimates of physical activity. Compared to females, males tended to have greater overall cardiorespiratory fitness, despite similar levels of disability. Next, associations between cardiorespiratory fitness, MVPA, and disability were statistically significant in females only. Lastly, the regression equation including age, sex, body mass, and EDSS and self-reported MET-minutes of MVPA predicted 35%-42% of variance in objectively measured V̇O_2max; however, self-reported MVPA was the only predictor variable that did not significantly contribute to the equation. The model was valid in females only. We believe these findings suggest that (1) persons with MS tended to overestimate their physical activity levels and (2) 24-hour physical activity recall was not a valid method for estimating cardiorespiratory fitness in persons with MS.

4.1. Low Cardiorespiratory Fitness in Males and Females with MS

In the present study, the V̇O_2max, based on 107 fitness tests conducted on an outpatient MS clinic sample, was mL·kg^-1·min^-1, representing fitness in the poor to fair range [16]. Approximately half of all participants had V̇O_2max fitness ranks below their age- and sex-normalized 20^th percentile [16]. Such low levels of fitness are concerning because of the links between low fitness, metabolic comorbidities, MS disability accumulation, and mortality [2, 3, 53]. A systematic review by Langeskov-Christensen et al. [18] reported similar V̇O_2max values in people with MS to those found here, but without considering sex differences [18].

In our sample, despite exceeding recommended physical activity levels based on 24-hour recall self-reports, both females ( mL·kg^-1·min^-1) and males ( mL·kg^-1·min^-1) failed to reach the range of “good” V̇O_2max values. There is limited research investigating sex-based differences in physical fitness in MS. A cross-sectional study by Romberg et al. [31] involving 92 individuals with MS (58 females), with a mean age of 44 years, reported fitness values similar to those reported here (21 mL·kg^-1·min^-1 for females and 27 mL·kg^-1·min^-1 for males) [31]. Interestingly, they reported significant associations between level of disability (EDSS) and fitness, which was stronger in males than females [31]. This finding conflicts with our result that lower disability was associated with higher V̇O_2max in females (, ) but not males (, ). These differences could be explained by the fact that in the Romberg et al. [31] study, males had higher mean disability scores (EDSS 3.0) than females (EDSS 2.2), while our median EDSS was 2.0 and the same for both sexes. It is important to note that their sample was recruited from a waitlist for inpatient rehabilitation, where participants presumably had rehabilitation needs for walking and balance. Conversely, our sample represents people attending regular outpatient neurology clinic visits, who were not referred to rehabilitation and had independent mobility and whose disease was stable. Given that males tend to have a more severe MS disease course [1], it is possible that their sample was representative of males with severe disease [31].

The method of fitness testing also influences V̇O_2max values. Previous studies [31] measured fitness using a cycle leg ergometer. The challenge with using a leg ergometer is that the workload is restricted to the lower limbs, such that individuals with greater leg weakness may not be able to reach their maximal values. Previous research confirmed that MS patients could achieve their predicted maximal fitness values when using both upper and lower body testing but not when using only the arms or legs [20]. In our study, we used a recumbent stepper, a device that has become widely available in the past 15 years and which permits workload distribution between the upper and lower body. Remarkably, even when using a more modern adapted device (recumbent stepper), our group of independent and clinically stable participants had fitness values in the poor to fair range.

4.2. Incongruence between Objective Fitness and Self-Reported Physical Activity

Participants reported 90 minutes of MVPA in the last 24 hours (412.5 MET-minutes). For comparison, we were unable to find other studies in MS using 24-hour physical activity recall. In representative MS studies using other self-report instruments, average weekly physical activity levels were variable and included 150 minutes per week of MVPA (≥4 MET) [63], 2710 MET-minutes per week of leisure-time activity of any type and intensity [45], and 1901 MET-minutes per week of at least low-intensity physical activity exceeding (≥3.3 MET) [46]. These observations suggest that participants in the current study tended to overestimate their levels of MVPA using 24-hour recall. Indeed, participants’ 24-hour MVPA estimates approached the weekly recommended 450 MET-minutes of MVPA from population physical activity guidelines [61, 62].

Although males tended to report higher levels of MVPA in the previous 24 hours than females (507 MET-minutes vs. 360 MET-minutes), this difference was not statistically significant (). Unlike females, males’ self-reported MVPA was not associated with cardiorespiratory fitness. In contrast to our findings, Anens et al. [64] reported lower physical activity levels in males with MS using the Physical Activity Disability Survey (PADS-R). The study suggested that more severe disease in males may limit their physical activity levels to a greater extent than females [64]. Notably, males and females in our sample had similar levels of disability on the neurologist-scored EDSS. Other studies using objective assessments such as uniaxial accelerometry [65] [66] or daily step counts measured by a motion sensor [67] or Fitbit Flex2 device [68] found no sex-related differences among individuals with MS. In a systematic review involving 58 studies, Streber et al. [69] reported that sex was inconsistently associated with physical activity in individuals with MS [69].

Subjective and objective measures of MVPA often show disparities in MS—possibly due to the misinterpretation of activity intensity—which can have significant implications when clinicians evaluate physical activity patterns in individuals with MS [30, 45]. One such source of overrepresentative physical activity self-reporting may be the use of a 24-hour recall instrument. Although these tools have been validated in healthy populations (Kozey [40–44]), previous-day estimates have been shown to misrepresent MVPA due to lack of standardized definitions of activity types and intensity [42–44], for uncommon or unfamiliar activities (Kozey [41]), and for persons with lower fitness [44]. Indeed, potential misclassification of self-reported physical activity in persons with MS can be attributed to a poor understanding or misinterpretation of activity intensity and duration [45]. Kinnett-Hopkins et al. [70] highlighted ambiguities in how individuals with MS perceive and interpret physical activity demands can contribute to challenges in accurately reporting their activity levels [70]. Such challenges are not exclusive to the MS population and have been observed in other chronic conditions such as diabetes [71], rheumatoid arthritis [72], and chronic low back pain [73]. These limitations can be circumvented by using standardized self-report tools that have been validated in the patient population, as well as operationalization of activity descriptions and intensities [74]. Alternatively, objective tools such as accelerometers may provide more valid characterization of physical activity levels [30, 45, 75, 76].

4.3. Limitations

One of the limitations of the current study was the self-report questionnaire used to estimate participants’ activities in the last 24 hours. We chose the 24-hour recall because of its lower vulnerability to recall bias compared to longer recall periods [26, 27]; however, previous-day estimates of activities may not represent a participant’s typical day, especially in persons with MS who may be more vulnerable to inaccurate recall than apparently healthy people. In addition to the timeframe of recall, the process of undertaking an open recall exercise is more nuanced than administering a structured questionnaire. This difference could impact interrater and test-retest reliability of MVPA estimates, thereby reducing the applicability of the present findings to wider clinical practice [45]. Objective measures of physical activity such as accelerometry yield more accurate MVPA results and may better identify sex differences when predicting V̇O_2max in future work [30]. Also, we did not explore factors like fatigue, pain, heat sensitivity, comorbidities, lifestyle factors, or medical treatments, nor how they relate to fitness. Since our regression model accounted for less than 50% of the variance in V̇O_2max, other unmeasured variables may be at play. Future work is needed to reexamine our findings by using other self-report tools or objective measures of MVPA.

5. Conclusions

Despite reporting high levels of MVPA, people with MS had low levels of cardiorespiratory fitness. MVPA, fitness, and disability were associated in females only, indicating that sex differences should be considered in fitness appraisal. Self-reported MVPA did not predict fitness, suggesting that 24-hour recall may not be representative of true activity or fitness levels in persons with MS. Low overall levels of fitness point to a need for exercise prescription to promote metabolic and brain health; however, sex should be considered during both fitness appraisal and exercise prescription. Future work should examine sex differences in associations between MVPA and fitness using objective measures such as accelerometry.

Data Availability

Data generated or analyzed during this study are available from the corresponding author upon reasonable request.

Disclosure

Contents within this manuscript were presented as an abstract at the 38^th Congress of the European Committee for Treatment and Rehabilitation in Multiple Sclerosis in Amsterdam, the Netherlands, on October 26-28, 2022, and published in Multiple Sclerosis.

Conflicts of Interest

The authors have no competing interests to declare.

Authors’ Contributions

Syamala Buragadda contributed to the conceptualization, data curation, and writing of the original draft preparation. Nicholas J. Snow was responsible for the methodology, formal analysis, and visualization and wrote, reviewed, and edited the manuscript. Alan P. C. Gou assisted in the investigation and data curation and wrote, reviewed, and edited the manuscript. Joshua N. McShane participated in the validation, investigation, and data curation. Caitlin J. Newell contributed to the project administration and data curation. Michelle Ploughman contributed to the conceptualization, methodology, funding acquisition, and project administration and wrote, reviewed, and edited the manuscript. The authors declare that the results of this study are presented honestly and without fabrication, falsification, or inappropriate data manipulation.

Acknowledgments

M.P. received funding from the Canadian Institutes for Health Research (Grant #s: 169649 and 173526), Newfoundland and Labrador Research and Development Corporation (Grant #: 5404.1699.104), and Canada Foundation for Innovation (Grant #: 33621). M.P. is currently receiving funding from the Canada Research Chairs Program (Grant #: 230457). S.B. is currently receiving an endMS Doctoral studentship from MS Canada (Award ID #: 1018271). We thank Drs. Fraser Clift and Mark Stefanelli for providing patient diagnoses, clinical documentation, and referrals. We thank the lab trainees who supported data collection and entry.

References

M. Filippi, A. Bar-Or, F. Piehl et al., “Multiple sclerosis,” Nature Reviews Disease Primers, vol. 4, no. 1, p. 43, 2018.
View at: Publisher Site | Google Scholar
R. A. Marrie, R. Patel, C. R. Figley et al., “Higher Framingham risk scores are associated with greater loss of brain volume over time in multiple sclerosis,” Multiple Sclerosis and Related Disorders, vol. 54, article 103088, 2021.
View at: Publisher Site | Google Scholar
R. A. Marrie, R. Rudick, R. Horwitz et al., “Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis,” Neurology, vol. 74, no. 13, pp. 1041–1047, 2010.
View at: Publisher Site | Google Scholar
R. W. Motl, B. M. Sandroff, G. Kwakkel et al., “Exercise in patients with multiple sclerosis,” The Lancet Neurology, vol. 16, no. 10, pp. 848–856, 2017.
View at: Publisher Site | Google Scholar
U. Dalgas, M. Langeskov-Christensen, E. Stenager, M. Riemenschneider, and L. G. Hvid, “Exercise as medicine in multiple sclerosis—time for a paradigm shift: preventive, symptomatic, and disease-modifying aspects and perspectives,” Current Neurology and Neuroscience Reports, vol. 19, no. 11, p. 88, 2019.
View at: Publisher Site | Google Scholar
A. J. Devasahayam, M. B. Downer, and M. Ploughman, “The effects of aerobic exercise on the recovery of walking ability and neuroplasticity in people with multiple sclerosis: a systematic review of animal and clinical studies,” Multiple Sclerosis International, vol. 2017, Article ID 4815958, 12 pages, 2017.
View at: Publisher Site | Google Scholar
A. J. Devasahayam, L. P. Kelly, J. B. Williams, C. S. Moore, and M. Ploughman, “Fitness shifts the balance of BDNF and IL-6 from inflammation to repair among people with progressive multiple sclerosis,” Biomolecules, vol. 11, no. 4, p. 504, 2021.
View at: Publisher Site | Google Scholar
M. Ploughman, M. W. Austin, L. Glynn, and D. Corbett, “The effects of poststroke aerobic exercise on neuroplasticity: a systematic review of animal and clinical studies,” Translational Stroke Research, vol. 6, no. 1, pp. 13–28, 2015.
View at: Publisher Site | Google Scholar
M. Ploughman and L. P. Kelly, “Four birds with one stone? Reparative, neuroplastic, cardiorespiratory, and metabolic benefits of aerobic exercise poststroke,” Current Opinion in Neurology, vol. 29, no. 6, pp. 684–692, 2016.
View at: Publisher Site | Google Scholar
R. Kalb, T. R. Brown, S. Coote et al., “Exercise and lifestyle physical activity recommendations for people with multiple sclerosis throughout the disease course,” Multiple Sclerosis Journal, vol. 26, no. 12, pp. 1459–1469, 2020.
View at: Publisher Site | Google Scholar
A. E. Latimer-Cheung, K. A. Martin Ginis, A. L. Hicks et al., “Development of evidence-informed physical activity guidelines for adults with multiple sclerosis,” Archives of Physical Medicine and Rehabilitation, vol. 94, no. 9, pp. 1829–1836.e7, 2013.
View at: Publisher Site | Google Scholar
D. Kinnett-Hopkins, B. Adamson, K. Rougeau, and R. W. Motl, “People with MS are less physically active than healthy controls but as active as those with other chronic diseases: an updated meta-analysis,” Multiple Sclerosis and Related Disorders, vol. 13, pp. 38–43, 2017.
View at: Publisher Site | Google Scholar
M. Ploughman, “Breaking down the barriers to physical activity among people with multiple sclerosis – a narrative review,” Physical Therapy Reviews, vol. 22, no. 3-4, pp. 124–132, 2017.
View at: Publisher Site | Google Scholar
L. A. Pilutti, M. E. Platta, R. W. Motl, and A. E. Latimer-Cheung, “The safety of exercise training in multiple sclerosis: a systematic review,” Journal of the Neurological Sciences, vol. 343, no. 1-2, pp. 3–7, 2014.
View at: Publisher Site | Google Scholar
C. M. Smith, L. A. Hale, K. Olson, G. D. Baxter, and A. G. Schneiders, “Healthcare provider beliefs about exercise and fatigue in people with multiple sclerosis,” Journal of Rehabilitation Research and Development, vol. 50, no. 5, pp. 733–744, 2013.
View at: Publisher Site | Google Scholar
G. Liguori and A. C. O. S. Medicine, ACSM's Guidelines for Exercise Testing and Prescription, Lippincott Williams & Wilkins, 2020.
M. Langeskov-Christensen, D. Langeskov-Christensen, K. Overgaard, A. B. Møller, and U. Dalgas, “Validity and reliability of VO₂-max measurements in persons with multiple sclerosis,” Journal of the Neurological Sciences, vol. 342, no. 1-2, pp. 79–87, 2014.
View at: Publisher Site | Google Scholar
M. Langeskov-Christensen, M. Heine, G. Kwakkel, and U. Dalgas, “Aerobic capacity in persons with multiple sclerosis: a systematic review and meta-analysis,” Sports Medicine, vol. 45, no. 6, pp. 905–923, 2015.
View at: Publisher Site | Google Scholar
C. M. Hesse, R. A. Tinius, B. C. Pitts et al., “Assessment of endpoint criteria and perceived barriers during maximal cardiorespiratory fitness testing among pregnant women,” Journal of Sports Medicine and Physical Fitness, vol. 58, no. 12, pp. 1844–1851, 2018.
View at: Publisher Site | Google Scholar
A. Kuspinar, R. E. Andersen, S. Y. Teng, M. Asano, and N. E. Mayo, “Predicting exercise capacity through submaximal fitness tests in persons with multiple sclerosis,” Archives of Physical Medicine and Rehabilitation, vol. 91, no. 9, pp. 1410–1417, 2010.
View at: Publisher Site | Google Scholar
R. W. Motl and B. Fernhall, “Accurate prediction of cardiorespiratory fitness using cycle ergometry in minimally disabled persons with relapsing-remitting multiple sclerosis,” Archives of Physical Medicine and Rehabilitation, vol. 93, no. 3, pp. 490–495, 2012.
View at: Publisher Site | Google Scholar
M. Valet, T. Lejeune, J. C. Hakizimana, and G. Stoquart, “Quality of the tools used to assess aerobic capacity in people with multiple sclerosis,” European Journal of Physical and Rehabilitation Medicine, vol. 53, no. 5, pp. 759–774, 2017.
View at: Publisher Site | Google Scholar
H. Beckerman, M. Heine, L. E. van den Akker, and V. de Groot, “The 2-minute walk test is not a valid method to determine aerobic capacity in persons with multiple sclerosis,” NeuroRehabilitation, vol. 45, no. 2, pp. 239–245, 2019.
View at: Publisher Site | Google Scholar
K. K. Mate, A. Kuspinar, S. Ahmed, and N. E. Mayo, “Comparison between common performance-based tests and self-reports of physical function in people with multiple sclerosis: does sex or gender matter?” Archives of Physical Medicine and Rehabilitation, vol. 100, no. 5, pp. 865–873.e5, 2019.
View at: Publisher Site | Google Scholar
M. Aadahl, M. Kjær, J. H. Kristensen, B. Mollerup, and T. Jørgensen, “Self-reported physical activity compared with maximal oxygen uptake in adults,” European Journal of Cardiovascular Prevention & Rehabilitation, vol. 14, no. 3, pp. 422–428, 2008.
View at: Publisher Site | Google Scholar
C. Cleland, S. Ferguson, G. Ellis, and R. F. Hunter, “Validity of the international physical activity questionnaire (IPAQ) for assessing moderate-to-vigorous physical activity and sedentary behaviour of older adults in the United Kingdom,” BMC Medical Research Methodology, vol. 18, no. 1, p. 176, 2018.
View at: Publisher Site | Google Scholar
M. Meeus, I. van Eupen, J. Willems, D. Kos, and J. Nijs, “Is the international physical activity questionnaire-short form (IPAQ-SF) valid for assessing physical activity in chronic fatigue syndrome?” Disability and Rehabilitation, vol. 33, no. 1, pp. 9–16, 2011.
View at: Publisher Site | Google Scholar
H. Shibasaki and V. Kuroiwa, “Sex difference of multiple sclerosis in Japan,” Neurology, vol. 26, no. 9, pp. 821–824, 1976.
View at: Publisher Site | Google Scholar
Z. Zhao, Y. Zhang, Q. Du et al., “Differences in physical, mental, and social functions between males and females in multiple sclerosis: a multicenter cross-sectional study in China,” Multiple Sclerosis and Related Disorders, vol. 48, article 102693, 2021.
View at: Publisher Site | Google Scholar
R. W. Motl, E. Mcauley, and E. M. Snook, “Physical activity and multiple sclerosis: a meta-analysis,” Multiple Sclerosis Journal, vol. 11, no. 4, pp. 459–463, 2005.
View at: Publisher Site | Google Scholar
A. Romberg, A. Virtanen, S. Aunola, S. L. Karppi, H. Karanko, and J. Ruutiainen, “Exercise capacity, disability and leisure physical activity of subjects with multiple sclerosis,” Multiple Sclerosis Journal, vol. 10, no. 2, pp. 212–218, 2004.
View at: Publisher Site | Google Scholar
M. L. Schlagheck, J. Bansi, C. Wenzel et al., “Complexity and pitfalls in maximal exercise testing for persons with multiple sclerosis,” European Journal of Neurology, vol. 30, no. 9, pp. 2726–2735, 2023.
View at: Publisher Site | Google Scholar
C. H. Polman, S. C. Reingold, B. Banwell et al., “Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria,” Annals of Neurology, vol. 69, no. 2, pp. 292–302, 2011.
View at: Publisher Site | Google Scholar
A. J. Thompson, B. L. Banwell, F. Barkhof et al., “Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria,” The Lancet Neurology, vol. 17, no. 2, pp. 162–173, 2018.
View at: Publisher Site | Google Scholar
J. F. Kurtzke, “Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS),” Neurology, vol. 33, no. 11, pp. 1444–1444, 1983.
View at: Publisher Site | Google Scholar
S. S. Bredin, N. Gledhill, V. K. Jamnik, and D. E. Warburton, “PAR-Q+ and ePARmed-X+: new risk stratification and physical activity clearance strategy for physicians and patients alike,” Canadian Family Physician, vol. 59, no. 3, pp. 273–277, 2013.
View at: Google Scholar
N. Carson, L. Leach, and K. J. Murphy, “A re-examination of Montreal cognitive assessment (MoCA) cutoff scores,” International Journal of Geriatric Psychiatry, vol. 33, no. 2, pp. 379–388, 2018.
View at: Publisher Site | Google Scholar
F. Faul, E. Erdfelder, A. G. Lang, and A. Buchner, “: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences,” Behavior Research Methods, vol. 39, no. 2, pp. 175–191, 2007.
View at: Publisher Site | Google Scholar
R. D. Snee, “Validation of regression models: methods and examples,” Technometrics, vol. 19, no. 4, pp. 415–428, 1977.
View at: Publisher Site | Google Scholar
C. E. Matthews, S. K. Keadle, J. Sampson et al., “Validation of a previous-day recall measure of active and sedentary behaviors,” Medicine and Science in Sports and Exercise, vol. 45, no. 8, pp. 1629–1638, 2013.
View at: Publisher Site | Google Scholar
S. Keadle, K. Lyden, A. Hickey et al., “Validation of a previous day recall for measuring the location and purpose of active and sedentary behaviors compared to direct observation,” International Journal of Behavioral Nutrition and Physical Activity, vol. 11, no. 1, p. 12, 2014.
View at: Publisher Site | Google Scholar
C. E. Matthews, D. Berrigan, B. Fischer et al., “Use of previous-day recalls of physical activity and sedentary behavior in epidemiologic studies: results from four instruments,” BMC Public Health, vol. 19, no. S2, p. 478, 2019.
View at: Publisher Site | Google Scholar
L. P. Saraiva Leão Borges, D. C. Ries, A. G. Sousa, and T. H. M. da Costa, “Comparison and calibration of 24-hour physical activity recall in adult population,” European Journal of Sport Science, vol. 22, no. 2, pp. 289–296, 2022.
View at: Publisher Site | Google Scholar
G. J. Welk, Y. Kim, B. Stanfill et al., “Validity of 24-h physical activity recall: physical activity measurement survey,” Medicine and Science in Sports and Exercise, vol. 46, no. 10, pp. 2014–2024, 2014.
View at: Publisher Site | Google Scholar
J. L. Gosney, J. A. Scott, E. M. Snook, and R. W. Motl, “Physical activity and multiple sclerosis: validity of self-report and objective measures,” Family & Community Health, vol. 30, no. 2, pp. 144–150, 2007.
View at: Publisher Site | Google Scholar
C. H. Marck, E. J. Hadgkiss, T. J. Weiland, D. M. van der Meer, N. G. Pereira, and G. A. Jelinek, “Physical activity and associated levels of disability and quality of life in people with multiple sclerosis: a large international survey,” BMC Neurology, vol. 14, no. 1, 2014.
View at: Publisher Site | Google Scholar
B. E. Ainsworth, W. L. Haskell, S. D. Herrmann et al., “2011 compendium of physical activities: a second update of codes and MET values,” Medicine and Science in Sports and Exercise, vol. 43, no. 8, pp. 1575–1581, 2011.
View at: Publisher Site | Google Scholar
F. C. Bull, S. S. al-Ansari, S. Biddle et al., “World Health Organization 2020 guidelines on physical activity and sedentary behaviour,” British Journal of Sports Medicine, vol. 54, no. 24, pp. 1451–1462, 2020.
View at: Publisher Site | Google Scholar
A. R. Chaves, L. P. Kelly, C. S. Moore, M. Stefanelli, and M. Ploughman, “Prolonged cortical silent period is related to poor fitness and fatigue, but not tumor necrosis factor, in multiple sclerosis,” Clinical Neurophysiology, vol. 130, no. 4, pp. 474–483, 2019.
View at: Publisher Site | Google Scholar
L. P. Kelly, A. J. Devasahayam, A. R. Chaves et al., “Intensifying functional task practice to meet aerobic training guidelines in stroke survivors,” Frontiers in Physiology, vol. 8, p. 809, 2017.
View at: Publisher Site | Google Scholar
G. Borg, Borg's Perceived Exertion and Pain Scales, Windsor, ON, Canada, Human Kinetics, 1998.
N. M. Beltz, A. L. Gibson, J. M. Janot, L. Kravitz, C. M. Mermier, and L. C. Dalleck, “Graded exercise testing protocols for the determination of VO₂max: historical perspectives, progress, and future considerations,” Journal of Sports Medicine, vol. 2016, Article ID 3968393, 12 pages, 2016.
View at: Publisher Site | Google Scholar
S. N. Blair, H. W. Kohl, C. E. Barlow, R. S. Paffenbarger, L. W. Gibbons, and C. A. Macera, “Changes in physical fitness and all-cause mortality: a prospective study of healthy and unhealthy men,” JAMA, vol. 273, no. 14, pp. 1093–1098, 1995.
View at: Publisher Site | Google Scholar
J. Cohen, Statistical Power Analysis for the Behavioral Sciences, Hillsdale, NJ, USA, Erlbaum, 1988.
R. S. Graves, J. D. Mahnken, R. D. Perea, S. A. Billinger, and E. D. Vidoni, “Modeling percentile rank of cardiorespiratory fitness across the lifespan,” Cardiopulmonary Physical Therapy Journal, vol. 26, no. 4, pp. 108–113, 2015.
View at: Publisher Site | Google Scholar
D. A. Lewis, E. Kamon, and J. L. Hodgson, “Physiological differences between genders. Implications for sports conditioning,” Sports Medicine, vol. 3, no. 5, pp. 357–369, 1986.
View at: Publisher Site | Google Scholar
J. Cohen, P. Cohen, S. G. West, and L. S. Aiken, Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences, Routledge, New York, NY, USA, 2003.
S. M. Schembre and D. A. Riebe, “Non-exercise estimation of VO₂ max using the international physical activity questionnaire,” Measurement in Physical Education and Exercise Science, vol. 15, no. 3, pp. 168–181, 2011.
View at: Publisher Site | Google Scholar
J. M. Bland and D. G. Altman, “Statistical methods for assessing agreement between two methods of clinical measurement,” Lancet, vol. 1, no. 8476, pp. 307–310, 1986.
View at: Google Scholar
D. J. Schuirmann, “A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability,” Journal of Pharmacokinetics and Biopharmaceutics, vol. 15, no. 6, pp. 657–680, 1987.
View at: Publisher Site | Google Scholar
K. L. Piercy, R. P. Troiano, R. M. Ballard et al., “The physical activity guidelines for Americans,” JAMA, vol. 320, no. 19, pp. 2020–2028, 2018.
View at: Publisher Site | Google Scholar
R. Singh, A. Pattisapu, and M. S. Emery, “US physical activity guidelines: current state, impact and future directions,” Trends in Cardiovascular Medicine, vol. 30, no. 7, pp. 407–412, 2020.
View at: Publisher Site | Google Scholar
H. Beckerman, V. de Groot, M. A. Scholten, J. C. E. Kempen, and G. J. Lankhorst, “Physical activity behavior of people with multiple sclerosis: understanding how they can become more physically active,” Physical Therapy, vol. 90, no. 7, pp. 1001–1013, 2010.
View at: Publisher Site | Google Scholar
E. Anens, M. Emtner, L. Zetterberg, and K. Hellström, “Physical activity in subjects with multiple sclerosis with focus on gender differences: a survey,” BMC Neurology, vol. 14, no. 1, p. 47, 2014.
View at: Publisher Site | Google Scholar
R. E. Klaren, R. W. Motl, D. Dlugonski, B. M. Sandroff, and L. A. Pilutti, “Objectively quantified physical activity in persons with multiple sclerosis,” Archives of Physical Medicine and Rehabilitation, vol. 94, no. 12, pp. 2342–2348, 2013.
View at: Publisher Site | Google Scholar
J. Fortune, M. Norris, A. Stennett et al., “Correlates of objectively measured physical activity among people with multiple sclerosis: a cross-sectional study,” Frontiers in Rehabilitation Sciences, vol. 2, article 726436, 2021.
View at: Publisher Site | Google Scholar
D. Dlugonski, L. A. Pilutti, B. M. Sandroff, Y. Suh, S. Balantrapu, and R. W. Motl, “Steps per day among persons with multiple sclerosis: variation by demographic, clinical, and device characteristics,” Archives of Physical Medicine and Rehabilitation, vol. 94, no. 8, pp. 1534–1539, 2013.
View at: Publisher Site | Google Scholar
V. J. Block, S. Cheng, J. Juwono et al., “Association of daily physical activity with brain volumes and cervical spinal cord areas in multiple sclerosis,” Multiple Sclerosis Journal, vol. 29, no. 3, pp. 363–373, 2023.
View at: Publisher Site | Google Scholar
R. Streber, S. Peters, and K. Pfeifer, “Systematic review of correlates and determinants of physical activity in persons with multiple sclerosis,” Archives of Physical Medicine and Rehabilitation, vol. 97, no. 4, pp. 633–645.e29, 2016.
View at: Publisher Site | Google Scholar
D. Kinnett-Hopkins, Y. Learmonth, E. Hubbard et al., “The interpretation of physical activity, exercise, and sedentary behaviours by persons with multiple sclerosis,” Disability and Rehabilitation, vol. 41, no. 2, pp. 166–171, 2019.
View at: Publisher Site | Google Scholar
M. R. Janevic, S. J. Mclaughlin, and C. M. Connell, “Overestimation of physical activity among a nationally representative sample of underactive Individuals with diabetes,” Medical Care, vol. 50, no. 5, pp. 441–445, 2012.
View at: Publisher Site | Google Scholar
C.-A. Yu, P. C. Rouse, J. J. C. S. Veldhuijzen van Zanten et al., “Subjective and objective levels of physical activity and their association with cardiorespiratory fitness in rheumatoid arthritis patients,” Arthritis Research & Therapy, vol. 17, no. 1, p. 59, 2015.
View at: Publisher Site | Google Scholar
A. Schaller, K. Rudolf, L. Dejonghe, C. Grieben, and I. Froboese, “Influencing factors on the overestimation of self-reported physical activity: a cross-sectional analysis of low back pain patients and healthy controls,” BioMed Research International, vol. 2016, Article ID 1497213, 11 pages, 2016.
View at: Publisher Site | Google Scholar
B. E. Ainsworth, C. J. Caspersen, C. E. Matthews, L. C. Mâsse, T. Baranowski, and W. Zhu, “Recommendations to improve the accuracy of estimates of physical activity derived from self report,” Journal of Physical Activity & Health, vol. 9, Supplement 1, pp. S76–S84, 2012.
View at: Publisher Site | Google Scholar
R. M. Boon, M. J. Hamlin, G. D. Steel, and J. J. Ross, “Validation of the New Zealand physical activity questionnaire (NZPAQ-LF) and the international physical activity questionnaire (IPAQ-LF) with accelerometry,” British Journal of Sports Medicine, vol. 44, no. 10, pp. 741–746, 2010.
View at: Publisher Site | Google Scholar
V. J. Silfee, C. F. Haughton, D. E. Jake-Schoffman et al., “Objective measurement of physical activity outcomes in lifestyle interventions among adults: a systematic review,” Preventive Medical Reports, vol. 11, pp. 74–80, 2018.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2024 Syamala Buragadda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

52

Downloads

31

Citations

Multiple Sclerosis International

Incongruence between Cardiorespiratory Fitness and Subjective Reports of Physical Activity in Multiple Sclerosis: A Focus on Sex Differences

Abstract

1. Introduction

2. Materials and Method

2.1. Participants

2.2. Self-Reported MVPA

2.3. Cardiorespiratory Fitness

2.4. Statistical Analysis

3. Results

3.1. Participants

3.2. Self-Reported MVPA and Cardiorespiratory Fitness

3.3. Associations between MVPA, V̇O2max, and Disability

3.4. Predicting V̇O2max from Self-Reported MVPA

4. Discussion

4.1. Low Cardiorespiratory Fitness in Males and Females with MS

4.2. Incongruence between Objective Fitness and Self-Reported Physical Activity

4.3. Limitations

5. Conclusions

Data Availability

Disclosure

Conflicts of Interest

Authors’ Contributions

Acknowledgments

References

Copyright

3.3. Associations between MVPA, V̇O_2max, and Disability

3.4. Predicting V̇O_2max from Self-Reported MVPA